Latin Resources receives $5 million injection to fund exploration

|

Published 07-DEC-2020 11:00 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Latin Resources Limited (ASX:LRS) has received firm commitments for a placement of 166,667,000 shares (Placement Shares) at an issue price of $0.03 per share to raise $5,000,010 (Placement).

The Placement Shares will be issued to sophisticated and professional investors of Euroz Hartleys Ltd (Euroz Hartleys) who acted as sole Lead Manager of Placement.

Proceeds from the placement will assist in funding a maiden air core drilling of the Noombenberry Halloysite Kaolin Project near Merredin in Western Australia.

The company recently announced that drilling at one of Australia’s few known occurrences of ultra-high-grade halloysite, a naturally occurring nanotube, would start in early December.

Drilling is designed to outline the extent of a known sub-outcrop occurrence of high quality kaolinitic clays and halloysite.

Kaolinitic clays and halloysite were identified in previous sampling where results confirmed up to 38.9% kaolinite and 15% halloysite by weight in the 45 – 180um size fraction.

Funding also to assist in first phase drilling at Yarara Gold Project

Another key priority is the company’s Yarara Gold Project in the Lachlan Fold Belt in New South Wales.

Complementing the Yarara Project was the recent securing of a major new project within the east Lachlan Fold Belt.

A new tenement application (ELA6145) was secured, covering some 280 square kilometres of highly prospective territory in the eastern Lachlan Fold Belt, straddling the regional scale Manildra Fault.

The project is 30 kilometres to the west of Orange in NSW, 30 kilometres to the north-west of the Newcrest’s (ASX:NCM) world class Cadia Gold-Copper Mine (22 million ounces gold, 4.3 million tonnes copper) and 60 kilometres west of Regis Resources’ (ASX:RRL) McPhillamys Gold Project (2 million ounces gold) which is hosted by similar geological trends, including being situated within the regional Lachlan Transverse Zone (LTZ).

Latin Resources will also be undertaking reconnaissance mapping and sampling at the recently acquired Manildra and Burdett Projects, as well as conducting first phase of reverse circulation (RC) drilling for approximately 1000 metres at these projects.

Commenting on the capital raising and the group’s upcoming activities, director Chris Gale said, “The interest shown by Euroz Hartleys’ clients in the capital raising is a testament to the quality of Latin’s projects that are now drill-ready and positioned to move into the next phase of development.

“The company has an extensive schedule of drilling across multiple targets planned to commence in December and continue throughout 2021, starting with the immediate drilling of our very exciting Noombenberry Halloysite-Kaolin Project in WA, and we’ll then embark upon our maiden gold drilling in the world-class gold district of the Lachlan Fold in the first quarter of 2021.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X